Back to KROS
Bank of New York Mellon Corp → KROS
Bank of New York Mellon Corp KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
19
Latest value
$11
Q3 2026
Peak value
$1.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.3M |
| Q4 2025 | $1.2M |
| Q4 2025 | $6K |
| Q4 2025 | $25K |
| Q4 2025 | $20 |
| Q1 2026 | $713K |
| Q1 2026 | $606K |
| Q1 2026 | $14K |
| Q1 2026 | $3K |
| Q1 2026 | $20 |
| Q2 2026 | $647K |
| Q2 2026 | $444K |
| Q2 2026 | $1K |
| Q2 2026 | $13K |
| Q2 2026 | $19 |
| Q3 2026 | $593K |
| Q3 2026 | $400K |
| Q3 2026 | $13K |
| Q3 2026 | $11 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11 | 1 | — | — |
| Q3 2026 | $13K | 1.1K | — | — |
| Q3 2026 | $400K | 35.1K | — | — |
| Q3 2026 | $593K | 52.0K | — | — |
| Q2 2026 | $19 | 2 | — | — |
| Q2 2026 | $13K | 1.3K | — | — |
| Q2 2026 | $1K | 126 | — | — |
| Q2 2026 | $444K | 41.5K | — | — |
| Q2 2026 | $647K | 60.5K | — | — |
| Q1 2026 | $20 | 2 | — | — |
| Q1 2026 | $3K | 292 | — | — |
| Q1 2026 | $14K | 1.2K | — | — |
| Q1 2026 | $606K | 54.9K | — | — |
| Q1 2026 | $713K | 64.5K | — | — |
| Q4 2025 | $20 | 1 | — | — |
| Q4 2025 | $25K | 1.2K | — | — |
| Q4 2025 | $6K | 292 | — | — |
| Q4 2025 | $1.2M | 57.1K | — | — |
| Q4 2025 | $1.3M | 62.9K | — | — |